FDA 483 - Omya, Inc - May 27, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Omya Inc., an API manufacturer in Superior, AZ, revealed significant deficiencies in computerized system controls and quality unit oversight. The firm failed to establish appropriate controls over electronic data, including signature removal, access permissions, data deletion, and backup schedules. Additionally, the quality unit was not adequately notified of production equipment alerts and preventative maintenance work orders, hindering their ability to investigate potential quality deficiencies.
ID · c15fda1a-c918-4741-94dd-205c503650f4